Skip to content

Profound Medical PROF Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
$1.31M-9.2%
Bioventus logo
BioventusBVS
$6.93M-30.3%
Globus Medical logo
Globus MedicalGMED
$115.22M+24.8%

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's operating lease liabilities (total)?
Profound Medical (PROF) reported operating lease liabilities (total) of $2.96M in Q1 2026.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.